脑动静脉畸形管理中的成本决定因素
研究纳入2012至2015年UCSF脑动静脉畸形登记中140例患者,计算所有归因于动静脉畸形的住院和门诊费用,用广义线性模型分析成本与住院时间的关联。总体中位成本为77865美元,术前栓塞加手术最贵(91948美元),放射外科最便宜(20917美元);出血、Spetzler-Martin分级和治疗方式是显著的成本预测因素。
要点
- 总体中位治疗成本为77865美元(四分位距49566-107448美元)。
- 术前栓塞加手术成本最高(91948美元),放射外科最低(20917美元)。
- 出血、Spetzler-Martin分级和治疗方式是显著的成本预测因素。
核心结论
- 出血、动静脉畸形分级和治疗方式是动静脉畸形管理中的显著成本决定因素。
- 术前栓塞加手术是最贵的治疗,放射外科最便宜,但手术病例的闭塞率显著更高。
研究设计与样本
- 研究纳入2012至2015年前瞻性登记于UCSF脑动静脉畸形登记并接受治疗的140例脑动静脉畸形患者。
- 从登记中收集患者和动静脉畸形特征、治疗类型、住院时间及影像学闭塞证据,计算所有归因于动静脉畸形的住院和门诊 encounter、干预和影像成本。
- 使用广义线性模型检验患者和动静脉畸形特征、治疗类型与成本和住院时间的关联,用Fisher精确检验比较不同治疗方式的影像学闭塞比例。
主要发现
- 总体中位治疗成本为77865美元(四分位距49566-107448美元)。
- 术前栓塞加手术是最贵的治疗,成本为91948美元(四分位距79914-140600美元),放射外科最便宜,为20917美元(四分位距13915-35583美元)。
- 在多预测因素分析中,出血、Spetzler-Martin分级和治疗类型是成本的显著预测因素。
- 接受手术的患者影像学闭塞率显著高于放射外科患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: There is little data on the cost of treating brain arteriovenous malformations (AVMs). The goal of this study then is to identify cost determinants in multimodal management of brain AVMs. METHODS: One hundred forty patients with brain AVMs prospectively enrolled in the UCSF brain AVM registry and treated between 2012 and 2015 were included in the study. Patient and AVM characteristics, treatment type, and length of stay and radiographic evidence of obliteration were collected from the registry. We then calculated the cost of all inpatient and outpatient encounters, interventions, and imaging attributable to the AVM. We used generalized linear models to test whether there was an association between patient and AVM characteristics, treatment type, and cost and length of stay. We tested whether the proportion of patients with radiographic evidence of obliteration differed between treatment modalities using Fisher's exact test. RESULTS: The overall median cost of treatment and interquartile range was $77,865 (49,566-107,448). Surgery with preoperative embolization was the costliest treatment at $91,948 (79,914-140,600), while radiosurgery was the least at $20,917 (13,915-35,583). In multi-predictor analyses, hemorrhage, Spetzler-Martin grade, and treatment type were significant predictors of cost. Patients who had surgery had significantly higher rates of obliteration compared with radiosurgery patients. CONCLUSIONS: Hemorrhage, AVM grade, and treatment modality are significant cost determinants in AVM management. Surgery with preoperative embolization was the costliest treatment and radiosurgery the least; however, surgical cases had significantly higher rates of obliteration.
引用
- Rutledge C, Nelson J, Lu A, et al. Cost determinants in management of brain arteriovenous malformations. Acta Neurochir (Wien). 2019. PMID: 31760534. doi:10.1007/s00701-019-04134-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。